Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
While compounding pharmacies were temporarily permitted to create semaglutide formulations similar to Ozempic, they must stop production now that the Ozempic and Wegovy shortage has been lifted
All information shared is based on preclinical research and laboratory studies
to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity and adults with overweight in the presence of at least one weight-related comorbid condition Limitations of Use: Concomitant use of Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended
Schoch, H
US$ 26.44
US$ 20.03
US$ 21.25
US$ 21.93
